Gonadal function in male and female patients with classic galactosemia.
BACKGROUND
Hypergonadotropic hypoestrogenic infertility is the most burdensome complication for females suffering from classic galactosemia. In contrast, male gonadal function seems less affected. The underlying mechanism is not understood and several pathogenic mechanisms have been proposed. Timing of the lesion, prenatal or chronic post-natal, or a combination of both are not yet clear.


METHODS
This review focuses on gonadal function in males and females, ovarian imaging and histology in this disease. It is based on the literature known to the authors and a Pubmed search using the keywords galactosemia, GALT deficiency, (premature) ovarian failure/insufficiency/dysfunction, testicular function, gonadotrophins, FSH, LH (published between January 1971 and April 2009).


RESULTS
Male gonads are less affected, boys spontaneously reach puberty, although onset can be delayed. Semen quality has not been extensively studied. Several affected males are known to have fathered a child. Female gonads are invariably affected, although to a varied extent (hypergonadotropic hypoestrogenic ovarian dysfunction). Intriguingly, FSH is often already increased in infancy. Imaging usually shows hypoplastic and streak-like ovaries. Histological findings in some cases reveal the presence of morphologically normal but decreased numbers of primordial follicles, with the absence of intermediate and Graafian follicles.


CONCLUSIONS
Gonads in males seem less affected than in females who exhibit hypergonadotropic hypoestrogenic subfertility. FSH can be elevated in infancy, and ovarian histology sometimes shows the presence of normal primordial follicles with absence of intermediate and Graafian follicles. These findings are similar to other genetic diseases primarily affecting the ovary.
Rubio-Gozalbo
M E
ME
Department of Pediatrics, Maastricht University Medical Center, Maastricht, The Netherlands. estela.rubio@mumc.nl
Gubbels
C S
CS
Bakker
J A
JA
Menheere
P P C A
PP
Wodzig
W K W H
WK
Land
J A
JA
D044127:Epigenesis, Genetic; D005260:Female; D005640:Follicle Stimulating Hormone / Q000502:physiology; D005693:Galactosemias / Q000150:complications / Q000235:genetics / Q000503:physiopathology*; D006801:Humans; D007247:Infertility, Female / Q000209:etiology / Q000503:physiopathology; D008297:Male; D010053:Ovary / Q000503:physiopathology*; D011247:Pregnancy; D016649:Primary Ovarian Insufficiency / Q000209:etiology / Q000503:physiopathology; D011962:Receptors, FSH / Q000502:physiology; D013737:Testis / Q000503:physiopathology*
D011962:Receptors, FSH; D005640:Follicle Stimulating Hormone